Literature DB >> 29540994

Corrigendum to "Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems".

Veronica Dusi1, Alice Ghidoni2,3, Alice Ravera4, Gaetano M De Ferrari1,3, Laura Calvillo2.   

Abstract

[This corrects the article DOI: 10.1155/2016/5902947.].

Entities:  

Year:  2018        PMID: 29540994      PMCID: PMC5818965          DOI: 10.1155/2018/4128049

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


In the article titled “Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems” [1], there was an error in Figure 2. The corrected figure is shown below.
Figure 1

Metabolic changes triggered by ischemic insult and possible evolutions of the injury with the crosstalk between chemokines. The pH decrease, provoked by ischemia, is the event turning on the process. The cell membrane is damaged and debris activates the classic complement pathway in the infarcted myocardium. ROS, adenosine, and complement activate mast cells to produce TNF and histamine, leading to leukocyte recruitment from the vessels. Depending on the presence or the absence of reperfusion, there is a different crosstalk between chemokines aimed at restoring the balance. Dysregulated or exaggerated responses may actually lead to a progression of the disease (see text for details, chemokines in red).

  1 in total

Review 1.  Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems.

Authors:  Veronica Dusi; Alice Ghidoni; Alice Ravera; Gaetano M De Ferrari; Laura Calvillo
Journal:  Mediators Inflamm       Date:  2016-05-03       Impact factor: 4.711

  1 in total
  1 in total

1.  Factors Associated with RANTES Concentration in Cardiovascular Disease Patients.

Authors:  Olga M Koper-Lenkiewicz; Joanna Kamińska; Anna Lisowska; Anna Milewska; Tomasz Hirnle; Violetta Dymicka-Piekarska
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.